Redcare Pharmacy, NL0012044747

Redcare Pharmacy stock ends week at EUR 77.90 before interim statement

Published on 10/25/2026 at 17:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Redcare Pharmacy stock trades at EUR 77.98 in weekend trading on October 25, 2026 versus the Xetra close of EUR 77.90. Statement is due October 29.

Dates frame the weekly balance

  • Redcare Pharmacy’s October 23 corporate item addressed digitalization in healthcare.
  • Redcare Pharmacy stock trades in weekend trading at Lang & Schwarz at EUR 77.98 at 5:55 p.m. CEST on October 25, 2026, 0.10 percent above the Xetra close of October 23, 2026.
  • The next Xetra session falls on October 26, 2026.
  • Redcare Pharmacy’s interim statement is scheduled for October 29, 2026.
Redcare Pharmacy (Shop Apoth), ISIN NL0012044747, dokumentiert Trading-Floor der AEX mit Pharma-Sektorcharts auf Großbildschirmen, Illustration mit AI erstellt.

Redcare Pharmacy stock stood at EUR 77.90 at the October 23, 2026, Xetra close. Lang & Schwarz priced the stock at EUR 77.98 in weekend trading at 5:55 p.m. CEST on October 25, 2026, 0.10 percent above that close. Redcare Pharmacy’s investor-relations calendar lists an interim statement for October 29, 2026, according to EQS News.

Market context: Market report DAX.

The week in figures

The Xetra close on October 23, 2026, was EUR 77.90. At Lang & Schwarz, the weekend price was EUR 77.98 at 5:55 p.m. CEST on October 25, 2026, equal to a 0.10 percent premium to the Xetra close of October 23, 2026.

The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.

Chronology of the week

On October 23, 2026, Redcare Pharmacy listed a corporate item titled “How can digitalization improve healthcare?” The item appears in the company’s latest-news listing on EQS News.

Dates of the coming week

The next Xetra session is scheduled for October 26, 2026. Redcare Pharmacy’s interim statement is listed for October 29, 2026, in the company’s upcoming-events information published by EQS News.

Disclaimer...
en | NL0012044747 | REDCARE PHARMACY | boerse | 70410679 | bgmi